Line 71: | Line 71: | ||
<br><br><br><br><br><br><br><br><br><br><br><br><br><br> | <br><br><br><br><br><br><br><br><br><br><br><br><br><br> | ||
<div class = "fixed_flyer" id = "sec1" style="position:relative;z-index:8;"> | <div class = "fixed_flyer" id = "sec1" style="position:relative;z-index:8;"> | ||
− | <div class = "h1" style="color:white"> | + | <div class = "h1" style="color:white">Overview</div> |
</div> | </div> | ||
<div class="pagediv"> | <div class="pagediv"> | ||
<br><br> | <br><br> | ||
− | <div class = "para"> | + | <div class = "para"> Photoacoustic imaging is a technique in which contrast agents absorb photon energy and emit signals that can be analyzed by ultrasound. Currently, photoacoustics is used to image blood vessels because heme is a natural contrast agent found in blood. Photoacoustic imaging also provides a non-invasive alternative to current diagnostic tools used to detect internal tissue inflammation. In previous literature, hypoxia and nitric oxide have both been discovered to molecularly indicate gut inflammation, and iRFP670, 713, anacy and cyan have been found to emit wavelengths that are different from heme and can penetrate tissue with near-infrared wavelengths. Therefore, our goal is to report inflammation and cancer in the gut through photoacoustic imaging of engineered E. coli that express bacterial pigment violacein, as well as near-infrared fluorescent proteins iRFP670 and iRFP713.</div> |
− | </div> | + | |
<br><br> | <br><br> | ||
</div> | </div> | ||
<div class = "fixed_flyer" id = "sec2" style="position:relative;z-index:9;"> | <div class = "fixed_flyer" id = "sec2" style="position:relative;z-index:9;"> | ||
− | <div class = "h1" style="color:white"> | + | <div class = "h1" style="color:white">Arabinose Induced iRFP 670 and 713 Fluorescence</div> |
</div> | </div> | ||
<div class="pagediv" style=" | <div class="pagediv" style=" | ||
Line 87: | Line 86: | ||
"> | "> | ||
<br><br> | <br><br> | ||
− | <div class = "para" style="text-align:left;width: 565px;"> | + | <div class = "para" style="text-align:left;width: 565px;"> |
+ | pBAD is a very well-characterized expression system in E. coli. pBAD normally works by arabinose induction: araC, a constitutively produced transcription regulator, changes form in the presence of arabinose sugar, allowing for the activation of promoter pBAD. Therefore, we formed genetic circuits consisting of the pBAD expression system and iRFP670 and 713 to test the inducibility of our iRFPs. <br><br> | ||
</div> | </div> | ||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
</div> | </div> | ||
<br><br> | <br><br> | ||
<div class = "fixed_flyer" id = "sec3" style="position:relative;z-index:10;"> | <div class = "fixed_flyer" id = "sec3" style="position:relative;z-index:10;"> | ||
− | <div class = "h1" style="color:white"> | + | <div class = "h1" style="color:white">Nitric-oxide-induced Fluorescence</div> |
</div> | </div> | ||
<div class="pagediv"> | <div class="pagediv"> | ||
<br><br> | <br><br> | ||
− | <div class = "para" style="float:left" | + | <div class = "para" style="float:left"> |
− | + | The next step was to test the nitric oxide induction of iRFP fluorescence. We used a genetic circuit consisting of a constitutive promoter that always expresses Part:BBa_K554003, which encodes for the expression of a SoxR. In the presence of nitric oxide, SoxR changes form to activate the promoter SoxS, which in turn is supposed to activate the expression of the iRFPs. Thus, for the next assay we added DETA/NO, a nitric oxide adduct in the presence of water. | |
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
</div> | </div> | ||
</div> | </div> |
Revision as of 02:51, 22 November 2016